Shahed University Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2013
NCT01759797
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Professor associated of neurology, Shahed University | Proffessor assistant of Shahed University

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Amyotrophic Lateral Sclerosis (Phase 1)

Motor Neuron Disease (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 3
  • # of Trial APIs: 3